Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Expression data from NSCs treated with REST inhibitor X5050


ABSTRACT: REST has been initially described as a repressor of neuronal genes in non-neuronal cells by binding to its recognition sequence RE1. Over-activation of this factor has been shown in several diseases such as Huntington disease or central nervous system cancers. High-throughput screening of a library of 6,984 compounds with luciferase-assay measuring REST activity in neural derivatives of human embryonic stem cells led to the identification of one benzoimidazole-5-carboxamide derivative (X5050) that inhibited REST silencing in a RE1-dependent manner. Differential transcriptomic analysis revealed the upregulation of neuronal genes targeted by REST. RNA was extracted from 6 samples, corresponding to 3 independent cultures of NSC SA-01, each one treated either with DMSO (0.1 % final) or with X5050 (100 µM final). RNA was isolated using RNeasy Mini kit with DNase I digestion and genome-wide gene expression profiling was performed by hybridization on Affymetrix microarrays

ORGANISM(S): Homo sapiens

SUBMITTER: Florent Dumont 

PROVIDER: E-GEOD-40695 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2013-10-01 | GSE40695 | GEO
2012-09-04 | E-GEOD-27114 | biostudies-arrayexpress
2012-09-04 | E-GEOD-27341 | biostudies-arrayexpress
2020-07-24 | GSE144226 | GEO
2012-06-06 | E-GEOD-38538 | biostudies-arrayexpress
2014-09-15 | PXD001127 | Pride
2019-09-03 | GSE119385 | GEO
2018-05-17 | GSE114541 | GEO
2013-01-01 | E-GEOD-34625 | biostudies-arrayexpress
2013-01-01 | GSE34625 | GEO